103 related articles for article (PubMed ID: 17454035)
1. Polyelectrolyte complexes of Eudragit l30 d-55 and gelatin: antinociceptive activity of entrapped piroxicam.
Attama AA
Drug Deliv; 2007 Mar; 14(3):155-62. PubMed ID: 17454035
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vivo evaluation of piroxicam-loaded gelatin microcapsule by spray drying technique.
Piao MG; Yang CW; Li DX; Kim JO; Jang KY; Yoo BK; Kim JA; Woo JS; Lyoo WS; Han SS; Lee YB; Kim DD; Yong CS; Choi HG
Biol Pharm Bull; 2008 Jun; 31(6):1284-7. PubMed ID: 18520070
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus.
Nnamani PO; Attama AA; Kenechukwu FC; Ibezim EC; Adikwu MU
Curr Drug Deliv; 2013 Dec; 10(6):645-55. PubMed ID: 23140234
[TBL] [Abstract][Full Text] [Related]
5. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
6. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
[TBL] [Abstract][Full Text] [Related]
7. Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug.
Nesseem DI; Eid SF; El-Houseny SS
Life Sci; 2011 Sep; 89(13-14):430-8. PubMed ID: 21777594
[TBL] [Abstract][Full Text] [Related]
8. Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.
Zhao L; Mustapha O; Shafique S; Jamshaid T; Din FU; Mehmood Y; Anwer K; Yousafi QUA; Hussain T; Khan IU; Ghori MU; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():8819-8828. PubMed ID: 33204090
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and evaluation of Eudragit
Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique.
Barzegar-Jalali M; Maleki N; Garjani A; Khandar AA; Haji-Hosseinloo M; Jabbari R; Dastmalchi S
Drug Dev Ind Pharm; 2002 Jul; 28(6):681-6. PubMed ID: 12149960
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro characterization of piroxicam enteric coated pellets using powder layering technique.
Varshosaz J; Tavakoli N; Serri A
Pharm Dev Technol; 2009; 14(3):305-11. PubMed ID: 19519183
[TBL] [Abstract][Full Text] [Related]
13. Increased localized delivery of piroxicam by cationic nanoparticles after intra-articular injection.
Kim SR; Ho MJ; Kim SH; Cho HR; Kim HS; Choi YS; Choi YW; Kang MJ
Drug Des Devel Ther; 2016; 10():3779-3787. PubMed ID: 27895468
[TBL] [Abstract][Full Text] [Related]
14. Applying a novel electrostatic dry powder coating technology to pellets.
Yang Q; Ma Y; Zhu J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of piroxicam from self-emulsifying lipospheres formulated with homolipids extracted from Capra hircus.
Attama AA; Mpamaugo VE
Drug Deliv; 2006; 13(2):133-7. PubMed ID: 16423801
[TBL] [Abstract][Full Text] [Related]
16. Sonication-assisted drug encapsulation in layer-by-layer self-assembled gelatin-poly (styrenesulfonate) polyelectrolyte nanocapsules: process optimization.
Pandey AP; Singh SS; Patil GB; Patil PO; Bhavsar CJ; Deshmukh PK
Artif Cells Nanomed Biotechnol; 2015; 43(6):413-24. PubMed ID: 24684490
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the microencapsulation process parameters piroxicam by complex coacervation].
Lamoudi L; Chaumeil JC; Daoud K
Ann Pharm Fr; 2015 Jan; 73(1):37-42. PubMed ID: 25577015
[TBL] [Abstract][Full Text] [Related]
18. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Evaluation of Diclofenac Sodium Tablet Coated with Polyelectrolyte Multilayer Film Using Hypromellose Acetate Succinate and Polymethacrylates for pH-Dependent, Modified Release Drug Delivery.
Jeganathan B; Prakya V; Deshmukh A
AAPS PharmSciTech; 2016 Jun; 17(3):578-87. PubMed ID: 26283195
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
Karataş A; Bekmezci S
Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
